{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-007857","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2026-10-15T12:00:14+00:00","discovered_at":"2026-10-15T12:05:00.145339+00:00","generated_at":"2026-10-15T12:05:16.606884+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.32,"calibrated_materiality_score":0.32,"confidence":"high","headline":"Valion Bio unit Velocity Bioworks completes initial feasibility test of LarmorBio BioScan-NMR platform","bullets":["Initial evaluation found a strong correlation between BioScan-NMR signal and optical density at 600 nm (OD600), a common measure of cell density in liquid cultures.","Milestone came less than six months after Valion Bio secured exclusive rights to LarmorBio's next-generation NMR technology.","Platform is being developed as process analytical technology to track cell size, density, viability and phenotype inside bioreactors via continuous, non-invasive closed-system monitoring.","Interim CEO Dean Zikria called it an 'early-stage proof-of-concept' with encouraging results; Velocity Bioworks will use the data to guide further development of continuous monitoring.","Stated goals include earlier detection of process deviations, fewer batch failures and lower manufacturing costs; no financial terms, revenue or timelines disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-007857","json":"https://secwatch.observer/filing/0001683168-26-007857.json","markdown":"https://secwatch.observer/filing/0001683168-26-007857.md","text":"https://secwatch.observer/filing/0001683168-26-007857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826007857/0001683168-26-007857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826007857/valion_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T12:05:16.606884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}